Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

NCT05480436 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemolysis
COVID-19

Interventions

BIOLOGICAL: coadministration
BIOLOGICAL: COVID-19 vaccine
BIOLOGICAL: IIV4+PPV23

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]